Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Zero based budgeting offers a fresh approach compared to traditional budgeting. Explore how these methods differ to find the best fit for your finances.
19,972 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Zeta Global is accelerating its AI-powered strategy, unlocking new growth channels and investor potential. This artic...
NVIDIA’s Q1 report after the bell is a pivotal test for the AI hardware rally. Traders will parse data-center growth,...
Rocket Lab has surged on new contracts and a growing backlog, yet investors wonder if the rally can last. This guide ...
Hedge funds are loading up on big software names as AI fuels new growth avenues, even as margins come under pressure....
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
A bold alliance between Allseas and a mining innovator aims to commercialize deep-sea nodule recovery. This strategic...
A sharp move lower has investors asking if the lululemon stock just 52-week headlines reflect a durable change or a t...
Investors are watching GameSquare closely as 2025 earnings unfold. This guide explains what to look for in the Q4 res...
Costco stands out not just as a warehouse retailer but as a potential long-term holding. This deep dive explores the ...
Poet Technologies has seen its stock retreat after a fast run-up. This guide breaks down why poet technologies stock ...